Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

The journal welcomes submissions in all of these fields.

Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.

  • Publishes research and reviews of mechanisms by which drugs affect behavior
  • Extends from clinical psychopharmacology to studies of effects of drugs on human cognition and behavior
  • Covers methodologies from neurochemical assays to functional neuroimaging studies
Coordinating editor
  • Trevor W. Robbins,
  • Christelle Baunez,
  • Patricia H. Janak
Principal editor
  • Harriet de Wit,
  • Valerie H Curran,
  • A. Leslie Morrow,
  • Kenji Hashimoto,
  • Oliver Howes,
  • Stan B. Floresco,
  • Deepak D'Souza
Speed
Submission to first decision: 52 days
Acceptance to publication: 15 days
Usage
Downloads: 1,025,632 (2018)
Impact
Impact factor: 3.424 (2018)
Five year impact factor: 3.300 (2018)
Publishing model
Hybrid. Open Choice – What is this?

Articles

Subscribe

Subscription
$199.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access
  • Full Journal access includes all articles
  • Downloadable in PDF
  • Subscription expires 12/31/2019

Advertisement

About this journal

Electronic ISSN
1432-2072
Print ISSN
0033-3158
Abstracted and indexed in
  1. BIOSIS
  2. Biological Abstracts
  3. CAB Abstracts
  4. Chemical Abstracts Service (CAS)
  5. Current Contents/ Life Sciences
  6. EBSCO Discovery Service
  7. EMBASE
  8. ERIH PLUS
  9. Gale
  10. Gale Academic OneFile
  11. Google Scholar
  12. Highbeam
  13. IFIS Publishing
  14. Institute of Scientific and Technical Information of China
  15. Japanese Science and Technology Agency (JST)
  16. Journal Citation Reports/Science Edition
  17. Medline
  18. Meta
  19. Naver
  20. OCLC WorldCat Discovery Service
  21. Pathway Studio
  22. ProQuest Agricultural & Environmental Science Database
  23. ProQuest Animal Behavior Abstracts
  24. ProQuest Biological Science Database
  25. ProQuest Central
  26. ProQuest Chemoreception Abstracts
  27. ProQuest Environmental Science
  28. ProQuest Health & Medical Collection
  29. ProQuest Health Research Premium Collection
  30. ProQuest Medical Database
  31. ProQuest Natural Science Collection
  32. ProQuest Neurosciences Abstracts
  33. ProQuest Nursing & Allied Health Database
  34. ProQuest Pharma Collection
  35. ProQuest Psychology Database
  36. ProQuest SciTech Premium Collection
  37. ProQuest Toxicology Abstracts
  38. ProQuest-ExLibris Primo
  39. ProQuest-ExLibris Summon
  40. PsycINFO
  41. Reaxys
  42. SCImago
  43. SCOPUS
  44. Science Citation Index
  45. Science Citation Index Expanded (SciSearch)
Copyright information

Rights and permissions

Springer Nature policies

© Springer-Verlag GmbH Germany, part of Springer Nature